Encyclopedia

  • An effective synthesis of an arabinogalactan with a β-(1 → 6)-linked galactopyranose backbone and α-(1 → 2) arabinofuranose side chains
  • Add time:08/23/2019         Source:sciencedirect.com

    An octasaccharide, β-d-Galp-(1 → 6)-[α-l-Araf-(1 → 2)]-β-d-Galp-(1 → 6)-β-d-Galp-(1 → 6)-[α-l-Araf-(1 → 5)-α-l-Araf-(1 → 2)]-β-d-Galp-(1 → 6)-β-d-Galp-1 → OMP was synthesized. 4-Methoxyphenyl 2,3,4-tri-O-benzoyl-β-d-galactopyranoside (5), 2,6-di-O-acetyl-3,4-di-O-benzoyl-α-d-galactopyranosyl trichloroacetimidate (9), and 4-methoxyphenyl 2-O-acetyl-3,4-di-O-benzoyl-β-d-galactopyranoside (11), 2,3,4,6-tetra-O-benzoyl-α-d-galactopyranosyl trichloroacetimidate (12), and 2,3,5-tri-O-benzoyl-α-l-arabinofuranosyl trichloroacetimidate (17) were used as the synthons. A concise route was used to gain the tetrasaccharide donor 19 by the use of 11, 12, 5, and 17. Meanwhile, treatment of 5 with 9 yielded β-(1 → 6)-linked disaccharide 20, and subsequent selective 6-O-deacetylation produced the disaccharide acceptor 21. Reaction of 21 with 19 gave 22, and subsequent selective 2-O-deacetylation afforded the hexasaccharide acceptor 23. Condensation of 23 with α-l-(1 → 5)-linked arabinofuranose disaccharide 24, followed by deprotection, yielded the target octasaccharide.

    We also recommend Trading Suppliers and Manufacturers of 2,3,4,6-TETRA-O-BENZOYL-A-D-GALACTOPYRANOSIDE TRICHLOROACETIMIDATE (cas 138479-78-4). Pls Click Website Link as below: cas 138479-78-4 suppliers


    Prev:Original articleSynthesis of some novel 3-(1-(1-substitutedpiperidin-4-yl)-1H-1,2,3-triazol-4-yl)-5-substituted phenyl-1,2,4-oxadiazoles as antifungal agents
    Next: Solid-phase synthesis of a glycosylated hexapeptide of human sialophorin, using the trichloroacetimidate method☆)

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View